BioLineRx (BLRX) Capital Expenditures Growth (3y) (2016 - 2024)
BioLineRx (BLRX) Capital Expenditures Growth (3y) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BioLineRx |
227.63 Mn |
211.90 Mn |
154,000.00 |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
27.99% |
| Jun 30, 2024 |
-12.43% |
| Mar 31, 2024 |
-18.98% |
| Dec 31, 2023 |
-162.07% |
| Dec 31, 2022 |
-63.67% |
| Sep 30, 2022 |
-128.94% |
| Jun 30, 2022 |
-25.99% |
| Mar 31, 2022 |
16.57% |
| Dec 31, 2021 |
13.86% |
| Jun 30, 2021 |
4.77% |
| Mar 31, 2021 |
29.40% |
| Dec 31, 2020 |
26.08% |
| Dec 31, 2019 |
-28.38% |
| Jun 30, 2019 |
6.60% |
| Mar 31, 2019 |
39.06% |
| Dec 31, 2018 |
23.54% |
| Jun 30, 2018 |
75.17% |
| Mar 31, 2018 |
28.70% |
| Dec 31, 2017 |
-94.76% |
| Sep 30, 2017 |
34.62% |
